Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews
- PMID: 28881002
- PMCID: PMC6483738
- DOI: 10.1002/14651858.CD012252.pub2
Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews
Abstract
Background: Antibiotic resistance is a worldwide health threat. Interventions that reduce antibiotic prescribing by clinicians are expected to reduce antibiotic resistance. Disparate interventions to change antibiotic prescribing behaviour for acute respiratory infections (ARIs) have been trialled and meta-analysed, but not yet synthesised in an overview. This overview synthesises evidence from systematic reviews, rather than individual trials.
Objectives: To systematically review the existing evidence from systematic reviews on the effects of interventions aimed at influencing clinician antibiotic prescribing behaviour for ARIs in primary care.
Methods: We searched the Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects (DARE), MEDLINE, Embase, CINAHL, PsycINFO, and Science Citation Index to June 2016. We also searched the reference lists of all included reviews. We ran a pre-publication search in May 2017 and placed additional studies in 'awaiting classification'.We included both Cochrane and non-Cochrane reviews of randomised controlled trials evaluating the effect of any clinician-focussed intervention on antibiotic prescribing behaviour in primary care. Two overview authors independently extracted data and assessed the methodological quality of included reviews using the ROBIS tool, with disagreements reached by consensus or by discussion with a third overview author. We used the GRADE system to assess the quality of evidence in included reviews. The results are presented as a narrative overview.
Main results: We included eight reviews in this overview: five Cochrane Reviews (33 included trials) and three non-Cochrane reviews (11 included trials). Three reviews (all Cochrane Reviews) scored low risk across all the ROBIS domains in Phase 2 and low risk of bias overall. The remaining five reviews scored high risk on Domain 4 of Phase 2 because the 'Risk of bias' assessment had not been specifically considered and discussed in the review Results and Conclusions. The trials included in the reviews varied in both size and risk of bias. Interventions were compared to usual care.Moderate-quality evidence indicated that C-reactive protein (CRP) point-of-care testing (risk ratio (RR) 0.78, 95% confidence interval (CI) 0.66 to 0.92, 3284 participants, 6 trials), shared decision making (odds ratio (OR) 0.44, 95% CI 0.26 to 0.75, 3274 participants, 3 trials; RR 0.64, 95% CI 0.49 to 0.84, 4623 participants, 2 trials; risk difference -18.44, 95% CI -27.24 to -9.65, 481,807 participants, 4 trials), and procalcitonin-guided management (adjusted OR 0.10, 95% CI 0.07 to 0.14, 1008 participants, 2 trials) probably reduce antibiotic prescribing in general practice. We found moderate-quality evidence that procalcitonin-guided management probably reduces antibiotic prescribing in emergency departments (adjusted OR 0.34, 95% CI 0.28 to 0.43, 2605 participants, 7 trials). The overall effect of these interventions was small (few achieving greater than 50% reduction in antibiotic prescribing, most about a quarter or less), but likely to be clinically important.Compared to usual care, shared decision making probably makes little or no difference to reconsultation for the same illness (RR 0.87, 95% CI 0.74 to 1.03, 1860 participants, 4 trials, moderate-quality evidence), and may make little or no difference to patient satisfaction (RR 0.86, 95% CI 0.57 to 1.30, 1110 participants, 2 trials, low-quality evidence). Similarly, CRP testing probably has little or no effect on patient satisfaction (RR 0.79, 95% CI 0.57 to 1.08, 689 participants, 2 trials, moderate-quality evidence) or reconsultation (RR 1.08, 95% CI 0.93 to 1.27, 5132 participants, 4 trials, moderate-quality evidence). Procalcitonin-guided management probably results in little or no difference in treatment failure in general practice compared to normal care (adjusted OR 0.95, 95% CI 0.73 to 1.24, 1008 participants, 2 trials, moderate-quality evidence), however it probably reduces treatment failure in the emergency department compared to usual care (adjusted OR 0.76, 95% CI 0.61 to 0.95, 2605 participants, 7 trials, moderate-quality evidence).The quality of evidence for interventions focused on clinician educational materials and decision support in reducing antibiotic prescribing in general practice was either low or very low (no pooled result reported) and trial results were highly heterogeneous, therefore we were unable draw conclusions about the effects of these interventions. The use of rapid viral diagnostics in emergency departments may have little or no effect on antibiotic prescribing (RR 0.86, 95% CI 0.61 to 1.22, 891 participants, 3 trials, low-quality evidence) and may result in little to no difference in reconsultation (RR 0.86, 95% CI 0.59 to 1.25, 200 participants, 1 trial, low-quality evidence).None of the trials in the included reviews reported on management costs for the treatment of an ARI or any associated complications.
Authors' conclusions: We found evidence that CRP testing, shared decision making, and procalcitonin-guided management reduce antibiotic prescribing for patients with ARIs in primary care. These interventions may therefore reduce overall antibiotic consumption and consequently antibiotic resistance. There do not appear to be negative effects of these interventions on the outcomes of patient satisfaction and reconsultation, although there was limited measurement of these outcomes in the trials. This should be rectified in future trials.We could gather no information about the costs of management, and this along with the paucity of measurements meant that it was difficult to weigh the benefits and costs of implementing these interventions in practice.Most of this research was undertaken in high-income countries, and it may not generalise to other settings. The quality of evidence for the interventions of educational materials and tools for patients and clinicians was either low or very low, which prevented us from drawing any conclusions. High-quality trials are needed to further investigate these interventions.
Conflict of interest statement
Sarah Tonkin‐Crine is a health psychologist funded by the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with Public Health England.
Pui San Tan is an infectious diseases and acute care postdoctoral researcher funded by the NIHR under its Programme Grants for Applied Research Programme (RP‐PG‐ 0514‐20015).
Oliver van Hecke is a general practitioner and clinical research fellow at the University of Oxford, funded by the NIHR under its Programme Grants for Applied Research Programme (RP‐PG‐1210‐12012).
Kay Wang is a NIHR postdoctoral fellow at the University of Oxford.
Nia Roberts: none known.
Amanda McCullough is a postdoctoral fellow at the Centre for Research Excellence in Minimising Antibiotic Resistance from Acute Respiratory Infections (CREMARA) funded by the National Health and Medical Research Council (NHMRC), Australia (1044904).
Malene Plejdrup Hansen was a postdoctoral fellow at the Centre for Research Excellence in Minimising Antibiotic Resistance from Acute Respiratory Infections (CREMARA) funded by the National Health and Medical Research Council (NHMRC), Australia (1044904), and is a senior research fellow at the Research Unit for General Practice in Aalborg funded by the Research Foundation of General Practice in Denmark.
Christopher C Butler has held research grants to develop, evaluate and implement antibiotic stewardship interventions. He has received honoraria from Alere and Roche for contributions about point of care diagnostics. The honorarium from Roche did not relate to this review in any way. He is the chief investigator of the publicly funded PACE study that is assessing C‐reactive protein point of care testing (CRP POCT) to guide antibiotic treatment for acute exacerbations of chronic obstructive airways disease. Alere has provided the CRP POCT devices and associated support as an unconditional educational grant free to the study. He also receives support from the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, and holds several publicly funded grants to conduct research in the field of infections. No commercial funding was received from any source to conduct this review.
Chris B Del Mar is co‐ordinating editor of the Cochrane Acute Respiratory Infections Group and chief investigator at the Centre for Research Excellence in Minimising Antibiotic Resistance from Acute Respiratory Infections (CREMARA) funded by the National Health and Medical Research Council (NHMRC), Australia (1044904). He received royalties from BMJ Books and Elsevier for activities unrelated to this submitted work.
Comment in
-
Review: In primary care, CRP testing, shared decision making, and procalcitonin reduce antibiotic prescribing for ARI.Ann Intern Med. 2018 Jan 16;168(2):JC11. doi: 10.7326/ACPJC-2018-168-2-011. Ann Intern Med. 2018. PMID: 29335723 No abstract available.
References
References to included reviews
Aabenhus 2014
-
- Aabenhus R, Jensen JUS, Jørgensen KJ, Hróbjartsson A, Bjerrum L. Biomarkers as point‐of‐care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD010130.pub2] - DOI - PubMed
Arnold 2005
Boonacker 2010
-
- Boonacker CWB, Hoes AW, Dikhoff M, Schilder AGM, Rovers MM. Interventions in health care professionals to improve treatment in children with upper respiratory tract infections. International Journal of Pediatric Otorhinolaryngology 2010;74:1113‐21. - PubMed
Coxeter 2015
de Bont 2015
Doan 2014
Huang 2013
References to excluded reviews
Andrews 2012
-
- Andrews T, Thompson M, Buckley DI, Heneghan C, Deyo R, Redmond N, et al. Interventions to influence consulting and antibiotic use for acute respiratory tract infections in children: a systematic review and meta‐analysis. PLoS ONE 2012;7(1):e30334. [DOI: 10.1371/journal.pone.0030334] - DOI - PMC - PubMed
Arroll 2003
Cooke 2015
Engel 2012
-
- Engel MF, Paling FP, Hoepelman AIM, Meer V, Oosterheert JJ. Evaluating the evidence for the implementation of C‐reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. Family Practice 2012;29:383‐93. - PubMed
Gross 2001
-
- Gross PA, Pujat D. Implementing practice guidelines for appropriate antimicrobial usage: a systematic review. Medical Care 2001;39(8):Suppl 2: II‐55‐69. - PubMed
Patel 2007
-
- Patel SJ, Larson EL, Kubin CJ, Saiman L. A review of antimicrobial control strategies in hospitalized and ambulatory pediatric populations. Pediatric Infectious Disease Journal 2007;26:531‐7. - PubMed
Petrozzino 2010
-
- Petrozzino JJ, Smith C, Atkinson MJ. Rapid diagnostic testing for seasonal influenza: an evidence‐based review and comparison with unaided clinical diagnosis. Journal of Emergency Medicine 2010;39(4):476‐90. - PubMed
Ranji 2008
-
- Ranji SR, Steinman MA, Shojania KG, Gonzales R. Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis. Medical Care 2008;46:847‐62. - PubMed
Rausch 2009
-
- Rausch S, Flammang M, Haas N, Stein R, Tabouring P, Delvigne S, et al. C‐reactive protein to initiate or withhold antibiotics in acute respiratory tract infections in adults, in primary care: review. Bulletin de la Société des sciences médicales du Grand‐Duché de Luxembourg [Bulletin of the Society of Medical Sciences of the Grand Duchy of Luxembourg] 2009;1:79‐87. - PubMed
Schuetz 2011
-
- Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Archives of Internal Medicine 2011;171(15):1322‐31. - PubMed
Schuetz 2013
Spurling 2013
van der Does 2016
-
- Does Y, Rood PPM, Haagsma JA, Patka P, Gorp ECM, Limper M. Procalcitonin‐guided therapy for the initiation of antibiotics in the ED: a systematic review. American Journal of Emergency Medicine 2016;34:1286–93. - PubMed
van der Velden 2012
Vodicka 2013
Additional references
ACSQHC 2016
-
- Australian Commission on Safety and Quality in Health Care (ACSQHC). AURA 2016: First Australian report on antimicrobial use and resistance in human health. www.safetyandquality.gov.au/publications/aura‐2016‐first‐australian‐repo... (accessed 20 April 2017).
Adriaenssens 2011
-
- Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, et al. European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). Journal of Antimicrobial Chemotherapy 2011;66(Suppl 6):vi3‐12. - PubMed
Altiner 2007
-
- Altiner A, Brockmann S, Sielk M, Wilm S, Wegscheider K, Abholz HH. Reducing antibiotic prescriptions for acute cough by motivating GPs to change their attitudes to communication and empowering patients: a cluster randomized intervention study. Journal of Antimicrobial Chemotherapy 2007;60:638‐44. - PubMed
Andreeva 2014
Bonner 2003
-
- Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of the rapid diagnosis of influenza on physician decision‐making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 2003;112(2):363‐7. - PubMed
Briel 2006
-
- Briel M, Langewitz W, Tschudi P, Young J, Hugenschmidt C, Bucher HC. Communication training and antibiotic use in acute respiratory tract infections. A cluster randomised controlled trial in general practice. Swiss Medical Weekly 2006;136:241‐7. - PubMed
Briel 2008
-
- Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, et al. Procalcitonin‐guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Archives of Internal Medicine 2008;168(18):2000‐7. - PubMed
Burkhardt 2010
-
- Burkhardt O, Ewig S, Haagen U, Giersdorf S, Hartmann O, Wegscheider K, et al. Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. European Respiratory Journal 2010;36(3):601‐7. - PubMed
Butler 2012
Cals 2009
Cals 2010
Cals 2011
-
- Cals JW, Ament AJ, Hood K, Butler CC, Hopstaken RM, Wassink GF, et al. C‐reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. Journal of Evaluation in Clinical Practice 2011;17(6):1059‐69. - PubMed
Cals 2013
CDC 2013
-
- Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. www.cdc.gov/drugresistance/threat‐report‐2013/index.html (accessed 16 March 2016).
Christ‐Crain 2004
-
- Christ‐Crain M, Jaccard‐Stolz D, Bingisser R, Gencay M, Huber P, Tamm M, et al. Effect of procalcitonin guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster‐randomised, single blinded intervention trial. Lancet 2004;1363(9409):600‐7. - PubMed
Christ‐Crain 2006
-
- Christ‐Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, et al. Procalcitonin guidance of antibiotic therapy in community‐acquired pneumonia: a randomized trial. American Journal of Respiratory and Critical Care Medicine 2006;174(1):84‐93. - PubMed
Christakis 2001
-
- Christakis DA, Zimmerman FJ, Wright JA, Garrison MM, Rivara FP, Davis RL. A randomized controlled trial of point‐of‐care evidence to improve the antibiotic prescribing practices for otitis media in children. Pediatrics 2001;107:E15. - PubMed
Chung 2007
Costelloe 2010
-
- Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta‐analysis. BMJ 2010;340:c2096. - PubMed
Davey 2017
Diederichsen 2000
-
- Diederichsen HZ, Skamling M, Diederichsen A, Grinsted P, Antonsen S, Petersen PH, et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scandinavian Journal of Primary Health Care 2000;18:39‐43. - PubMed
Doan 2009
-
- Doan Q, Kissoon N, Whitehouse S, Dobson S, Cochrane D, Schmidt B, et al. A randomized, controlled trial of the impact of early and rapid diagnosis of viral infections in children brought to an Emergency Department with febrile respiratory tract illnesses. Journal of Pediatrics 2009;154(1):91‐5. - PubMed
Finkelstein 2001
-
- Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, Rifas‐Shiman SL, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics 2001;108:1‐7. - PubMed
Flottorp 2002
Francis 2009
Gonzales 2011
-
- Gonzales R, Aagaard EM, Camargo CA Jr, Ma OJ, Plautz M, Maselli J, et al. C‐reactive protein testing does not decrease antibiotic use for acute cough illness when compared to a clinical algorithm. Journal of Emergency Medicine 2011;41(1):1‐7. - PubMed
Goossens 2005
-
- Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross‐national database study. Lancet 2005;365(9459):579‐87. - PubMed
Gulliford 2014
Guyatt 2008
Higgins 2011
-
- Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hu 2016
-
- Hu Y, Walley J, Chou R, Tucker JD, Harwell JI, Wu X, et al. Interventions to reduce childhood antibiotic prescribing for upper respiratory infections: systematic review and meta‐analysis. Journal of Epidemiology & Community Health 2016;70:1162–70. - PubMed
Huttner 2013
Kristoffersen 2009
-
- Kristoffersen KB, Sogaard OS, Wejse C, Black FT, Greve T, Tarp B, et al. Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission ‐ a randomized trial. Clinical Microbiology and Infection 2009;15(5):481‐7. - PubMed
Lancet 2009
-
- Urgently needed: new antibiotics. Lancet 2009;374(9705):1868. - PubMed
Little 2013
-
- Little P, Stuart B, Francis N, Tonkin‐Crine S, Douglas E, Anthierens S, et al. The effect of web‐based training in communication skills and an interactive patient booklet and the use of a CRP point of care test in acute respiratory tract infection (RTI): a multi‐national cluster randomised factorial controlled trial. Lancet 2013;382(9899):1175‐82. - PMC - PubMed
Long 2009
-
- Long W, Deng XQ, Tang JG, Xie J, Zhang YC, Zhang Y, et al. Procalcitonin‐guidance for reduction of antibiotic use in low‐risk outpatients with community acquired pneumonia. Zhonghua Nei Ke Za Zhi 2009;48(3):216‐9. - PubMed
Long 2011
-
- Long W, Deng X, Zhang Y, Lu G, Xie J, Tang J. Procalcitonin‐guidance for reduction of antibiotic use in low‐risk outpatients with community acquired pneumonia. Respirology 2011;76(1):266‐9. - PubMed
Légaré 2011
Légaré 2012
Macfarlane 1997
Mainous 2000
-
- Mainous AG 3rd, Hueston WJ, Love MM, Evans ME, Finger R. An evaluation of statewide strategies to reduce antibiotic overuse. Family Medicine 2000;32:22‐9. - PubMed
Makoul 2006
-
- Makoul G, Clayman ML. An integrative model of shared decision making in medical encounters. Patient Education and Counseling 2006;60:301‐12. - PubMed
Malhotra‐Kumar 2007
-
- Malhotra‐Kumar S, Lammens C, Coenen S, Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide‐resistant streptococci in healthy volunteers: a randomised, double‐blind, placebo‐controlled study. Lancet 2007;369(9560):482‐90. - PubMed
Martinez‐Gonzalez 2017
-
- Martinez‐Gonzalez NA, Coenen S, Plate A, Colliers A, Rosemann T, Senn O, et al. The impact of interventions to improve the quality of prescribing and use of antibiotics in primary care patients with respiratory tract infections: a systematic review protocol. BMJ Open 2017;7(6):e016253. - PMC - PubMed
McDonagh 2016
-
- McDonagh M, Peterson K, Winthrop K, Cantor A, Holzhammer B, Buckley DI. Improving antibiotic prescribing for uncomplicated acute respiratory tract infections. Rockville (MD): Agency for Healthcare Research and Quality; January 2016. Comparative Effectiveness Review No. 163. (Prepared by the Pacific Northwest Evidence‐based Practice Center under Contract No. 290‐2012‐00014‐I.) AHRQ Publication Number: 15(16)‐EHC033‐ EF.. - PubMed
McIsaac 1998
-
- McIsaac WJ, Goel V. Effect of an explicit decision‐support tool on decisions to prescribe antibiotics for sore throat. Medical Decision Making 1998;18:220‐8. - PubMed
McIsaac 2002
-
- McIsaac WJ, Goel V, To T, Permaul JA, Low DE. Effect on antibiotic prescribing of repeated clinical prompts to use a sore throat score: lessons from a failed community intervention study. Journal of Family Practice 2002;51:339‐44. - PubMed
Melbye 1995
-
- Melbye H, Aaraas I, Fleten N, Kolstrup N, Mikalsen J‐I. The value of C‐reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults [Nytten av å teste C–reaktivt protein ved mulig nedre luftveisinfeksjon. En undersøkelse fran allmennpraksis av en hurtigtests innvirkning på antibiotikaforskrivning og sykdomsforløp hos voksne]. Tidsskrift for Norske Laegeforeningen 1995;115(13):1610–5. - PubMed
Moore 2015
O'Neill 2014
-
- O'Neill J, Davies S, Rex J, White LJ, Murray R. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. amr‐review.org/sites/default/files/AMR%20Review%20Paper%20‐%20Tackling%20a%2... (accessed 20 April 2017).
O'Sullivan 2016
-
- O’Sullivan JW, Harvey RT, Glasziou PP, McCullough A. Written information for patients (or parents of child patients) to reduce the use of antibiotics for acute upper respiratory tract infections in primary care. Cochrane Database of Systematic Reviews 2016, Issue 11. [DOI: 10.1002/14651858.CD011360.pub2] - DOI - PMC - PubMed
PHE 2013
-
- Public Health England. UK One Health Report. Joint report on human and animal antibiotic use, sales and resistance, 2013. www.gov.uk/government/uploads/system/uploads/attachment_data/file/447319... (accessed 13 June 2016).
Poehling 2006
-
- Poehling KA, Zhu Y, Tang YW, Edwards K. Accuracy and impact of a point‐of‐care rapid influenza test in young children with respiratory illnesses. Archives of Pediatrics and Adolescent Medicine 2006;160(7):713‐8. - PubMed
RevMan 2014 [Computer program]
-
- The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schuetz 2009
-
- Schuetz P, Christ‐Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin‐based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009;302(10):1059‐66. - PubMed
Shapiro 2014
-
- Shapiro DJ, Hicks LA, Pavia AT, Hersh AL. Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09. Journal of Antimicrobial Chemotherapy 2014;69(1):234‐40. - PubMed
Smith 2013
-
- Smith R, Coast J. The true cost of antimicrobial resistance. BMJ 2013;346:f1493. - PubMed
Smith 2014
Spellberg 2013
Spinks 2013
Stolz 2007
-
- Stolz D, Christ‐Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin‐guidance with standard therapy. Chest 2007;131(1):9‐19. - PubMed
Tonkin‐Crine 2011
-
- Tonkin‐Crine S, Yardley L, Little P. Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta‐ethnography. Journal of Antimicrobial Chemotherapy 2011;66(10):2215‐23. - PubMed
Van Boeckel 2014
-
- Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infectious Diseases 2014;14(8):742‐50. - PubMed
Venekamp 2015
Welschen 2004
Whiting 2016
WHO 2015
-
- World Health Organization. Global action plan on antimicrobial resistance, 2015. apps.who.int/iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1 (accessed 13 June 2016).
Wilson 2002
-
- Wilson EJ. Realities of practice: development and implementation of clinical practice guidelines for acute respiratory infections in young children (PhD thesis). The Australian National University 2002.
Yardley 2013
-
- Yardley L, Douglas E, Anthierens S, Tonkin‐Crine S, O'Reilly G, Stuart B, et al. Evaluation of a web‐based intervention to reduce antibiotic prescribing in six European countries; quantitative process analysis of the GRACE/INTRO randomised controlled trial. Implementation Science 2013;8:134. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous